Bile Duct Injuries During Laparoscopic Cholecystectomies: An 11-year Population-based Study

NCT ID: NCT05479227

Last Updated: 2022-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

241 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-01

Study Completion Date

2022-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this retrospective study is to review the annual incidence, management, and outcomes of bile duct injuries (BDI) during laparoscopic cholecystectomy (LC) in a population-based cohort during 2008-2018 in Estonia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this retrospective study is to review the annual incidence, management, and outcomes of bile duct injuries (BDI) during laparoscopic cholecystectomy (LC) in a population-based cohort during 2008-2018 in Estonia.

Background Data: Iatrogenic bile duct injuries (BDI) following laparoscopic cholecystectomy (LC) result in major morbidity and incidental mortality. There is a lack of unselected population-based cross-sectional studies on the incidence, management, and outcomes of BDI. We hypothesised that due to improved imaging capabilities and collective laparoscopic experience, the BDI incidence will decrease over the study period and compare favourably with contemporary literature.

After IRB approval, all cholecystectomies performed at national public healthcare facilities between 2008 and 2018 were retrospectively reviewed. BDIs were classified according to the Strasberg classification. We hypothesized that due to improved imaging capabilities and collective laparoscopic experience the BDI incidence will decrease over the study period and compare favourably to contemporary literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bile Duct Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with bile duct injuries during laparoscopic cholecystectomy

The data concerning 241 patients´ BDI emergence, severity, management, and outcomes was analyzed

Management of bile duct injury

Intervention Type PROCEDURE

There are different options for BDI management, we analyzed their utilization and results

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Management of bile duct injury

There are different options for BDI management, we analyzed their utilization and results

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients with BDI during laparoscopic cholecystectomy (LC)

Exclusion Criteria

* The sole exclusion criterion in the case selection was cholecystectomy performed primarily using the open method
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Tartu

OTHER

Sponsor Role collaborator

North Estonia Medical Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arvo Reinsoo

Principal investigator, general surgeon, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arvo Reinsoo, MD

Role: PRINCIPAL_INVESTIGATOR

North Estonia Medical Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arvo Reinsoo

Tallinn, , Estonia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Estonia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AR

Identifier Type: -

Identifier Source: org_study_id